Chromocell Therapeutics Corp (CIK: 0001919246) EDGAR, Information, Filings... CompaniesBIO.Com

Chromocell Therapeutics Corp

Mailing address
685 US HIGHWAY ONE, NORTH BRUNSWICK, Delaware, 08902
Phone
9176446313
State location
New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Chromocell Therapeutics Corp (CIK: 0001919246) is an American company incorporated in the state of New Jersey. Head office is located at 685 US HIGHWAY ONE, NORTH BRUNSWICK, New Jersey, 08902. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Chromocell Therapeutics Corp is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Chromocell Therapeutics Corp

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001919246-26-000014 (34 Act) Size: KB	Mar-19-2026	001-41964 26772344
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001919246-26-000013 (34 Act) Size: KB	Mar-19-2026	001-41964 26772339
SCHEDULE 13G/A	Document	Acc-no: 0001193125-26-055097 (34 Act) Size: KB	Feb-17-2026	005-94460 26643486
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001753926-26-000321 (33 Act) Size: KB	Feb-13-2026	333-293133 26633086
EFFECT	Document	Acc-no: 9999999995-26-000493 (33 Act) Size: KB	Feb-09-2026	333-293133 26613335
SCHEDULE 13G/A	Document	Acc-no: 0001753926-26-000273 (34 Act) Size: KB	Feb-05-2026	005-94460 26602940
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0001753926-26-000231 (33 Act) Size: KB	Feb-02-2026	333-293133 26588605
8-K	Document	Current report filing Acc-no: 0001753926-26-000097 (34 Act) Size: KB	Jan-13-2026	001-41964 26528522
8-K	Document	Current report filing Acc-no: 0001753926-26-000094 (34 Act) Size: KB	Jan-12-2026	001-41964 26527179
8-K	Document	Current report filing Acc-no: 0001753926-26-000010 (34 Act) Size: KB	Jan-02-2026	001-41964 26502956
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001753926-25-001991 ( Act) Size: 0 KB	Dec-29-2025
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001753926-25-001990 ( Act) Size: 0 KB	Dec-29-2025
8-K	Document	Current report filing Acc-no: 0001753926-25-001964 (34 Act) Size: KB	Dec-23-2025	001-41964 251601878
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001193125-25-326891 ( Act) Size: 0 KB	Dec-19-2025
8-K	Document	Current report filing Acc-no: 0001753926-25-001906 (34 Act) Size: KB	Dec-17-2025	001-41964 251579474
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001753926-25-001884 ( Act) Size: 0 KB	Dec-12-2025
ARS	Document	Annual report to security holders Acc-no: 0001753926-25-001847 (34 Act) Size: KB	Dec-01-2025	001-41964 251540300
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001753926-25-001831 ( Act) Size: 0 KB	Nov-26-2025
DEF 14A	Document	Definitive proxy statements Acc-no: 0001753926-25-001827 (34 Act) Size: KB	Nov-25-2025	001-41964 251515307
D	Document	Acc-no: 0001919246-25-000006 (33 Act) Size: KB	Nov-19-2025	021-564384 251496368

Recent 20 filings. View all Chromocell Therapeutics Corp filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Chromocell Therapeutics Corp overview
Chromocell Therapeutics Corp job
Chromocell Therapeutics Corp stock
Chromocell Therapeutics Corp ownership
Chromocell Therapeutics Corp CEO
Chromocell Therapeutics Corp documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.